insulin infusion set 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Cellnovo 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2014-07-15
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Press release
  • 원인
    Safety alert on cellnovo insulin infusion set the department of health (dh) today (july 15) warned the public not to use the infusion set 5mm stainless steel (part no.: 5mm-inf5) and infusion set 8mm stainless steel (part no.: 8mm-inf5), manufactured by cellnovo, because of the possibility that the stainless steel needle may detach itself. the dh, through its routine surveillance of medical devices, noticed the safety alert from the medicines and healthcare products regulatory agency (mhra) of the united kingdom. according to the alert, there is a remote possibility that the stainless steel needle may detach itself while the patient is attempting to remove the infusion set during the changeover to a new insulin cartridge. the detachment of the needle does not pose a risk to safety, however it may not be possible for the patient to remove the needle without seeking professional medical assistance. the alert indicated that the manufacturer will supply the patient with new replacement infusion sets. patients are advised to pass the entire stock of unused infusion sets to the manufacturer for safe and correct disposal. the dh is checking with the manufacturer whether the affected products have been distributed to hong kong. no adverse incident related to the affected products has been reported in hong kong so far. if you are in possession of the products, please contact your supplier for necessary actions. the dh has informed the hospital authority, private hospitals and relevant medical professional associations about the matter and advised them to remain vigilant. the spokesman said, "the dh will closely monitor developments. members of the public should consult their healthcare professionals for advice if in doubt." ends.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Press release: Safety alert on Cellnovo insulin infusion set
  • Manufacturer

Manufacturer